$0.01
(0.02%)
| Today's Open | $54.89 |
|---|---|
| Previous Close | $55.48 |
| Daily Range | $54.16 - $56.06 |
| 52-Week Range | $24.12 - $58.07 |
| Market Cap | $84.6B |
| P/E Ratio | 31.25 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 10,769,704 |
| Average Daily Volume | 13,455,157 |
| Current FY EPS | $1.90 |
Sector
Healthcare
Industry
Drugs
Gilead Sciences (GILD) Description
Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/
News & Commentary
How is one of the pioneers of biotech doing lately? Find out in this month's Amgen stock checkup.
Pre-Market Most Active for May 22, 2013 : NTAP, PFE, NMR, RDS/A, RDS/B, NOK, SNE, PGTI, IRWD, GILD,
Pre-Market Most Active for May 22, 2013 : NTAP, PFE, NMR, RDS/A, RDS/B, NOK, SNE, PGTI, IRWD, GILD, VOD, ZNGAGILD's Top Competitors
(0.00%)
(0.00%)
(0.00%)